BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17973880)

  • 1. Nail pigmentation due to hydroxycarbamide.
    Ceulen RP; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Longitudinal melanonychia and hydroxyurea].
    Pirard C; Michaux JL; Bourlond A
    Ann Dermatol Venereol; 1994; 121(2):106-9. PubMed ID: 7979014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal melanonychia in a patient with essential thrombocytosis under treatment with hydroxyurea.
    Clerico R; Corsetti P; Ambrifi M; Paolino G; Rossi MR; Bottoni U; Calvieri S
    Acta Dermatovenerol Croat; 2012; 20(4):281-3. PubMed ID: 23317494
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal, transverse, and diffuse nail hyperpigmentation induced by hydroxyurea.
    Hernández-Martín A; Ros-Forteza S; de Unamuno P
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):333-4. PubMed ID: 10426924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nail pigmentation caused by hydroxyurea: report of 9 cases.
    Aste N; Fumo G; Contu F; Aste N; Biggio P
    J Am Acad Dermatol; 2002 Jul; 47(1):146-7. PubMed ID: 12077597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subungual melanoma complicated by hydroxyurea-induced melanonychia with non-melanoma Hutchinson's sign.
    Saito A; Fujisawa Y; Maruyama H; Nakamura Y; Ishitsuka Y; Watanabe R; Okiyama N; Fujimoto M
    Eur J Dermatol; 2018 Aug; 28(4):559-561. PubMed ID: 29941409
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review.
    Issaivanan M; Mitu PS; Manisha C; Praveen K
    Pediatr Dermatol; 2004; 21(2):124-7. PubMed ID: 15078351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
    Saraceno R; Teoli M; Chimenti S
    Clin Ther; 2008 Jul; 30(7):1324-9. PubMed ID: 18691992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.
    Zargari O; Kimyai-Asadi A; Jafroodi M
    Pediatr Dermatol; 2004; 21(6):633-5. PubMed ID: 15575845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis.
    Karanth SS; Gupta A; Prabhu M
    Singapore Med J; 2014 Jan; 55(1):e7-8. PubMed ID: 24452985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Longitudinal melanonychia induced by hydroxyurea therapy].
    Neynaber S; Wolff H; Plewig G; Wienecke R
    J Dtsch Dermatol Ges; 2004 Jul; 2(7):588-91. PubMed ID: 16281621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-Nail Transverse Melanonychia Induced by Hydroxyurea: Case Report and Review of the Literature.
    Osemwota O; Uhlemann J; Rubin A
    J Drugs Dermatol; 2017 Aug; 16(8):814-815. PubMed ID: 28809997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis.
    Cohen AD; Hallel-Halevy D; Hatskelzon L; Peretz E; Halevy S
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):137-9. PubMed ID: 10568495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea-induced nail pigmentation in HIV patients.
    Joyner S; Lee D; Hay P; Lau R
    HIV Med; 1999 Oct; 1(1):40-2. PubMed ID: 11737328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transverse melanonychia and palmar hyperpigmentation secondary to hydroxyurea therapy.
    Schoenfeld J; Tulbert BH; Cusack CA
    Cutis; 2017 May; 99(5):E2-E4. PubMed ID: 28632807
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient.
    Laughon SK; Shinn LL; Nunley JR
    Int J Dermatol; 2000 Dec; 39(12):928-31. PubMed ID: 11168664
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyurea-induced hyperpigmentation with iron deposition.
    Lee KP; Vangipuram RK; Klimas NK; Sanyal S; Koshelev MV
    Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toenails melanonychia induced by hydroxyurea.
    Kluger N; Naud M; Françès P
    Presse Med; 2012 Apr; 41(4):444-5. PubMed ID: 21996473
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyurea-induced nail pigmentation.
    Kwong YL
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):275-6. PubMed ID: 8708039
    [No Abstract]   [Full Text] [Related]  

  • 20. Longitudinal melanonychia induced by hydroxyurea: four case reports and review of the literature.
    Delmas-Marsalet B; Beaulieu P; Teillet-Thiebaud F; Jary L; Teillet F
    Nouv Rev Fr Hematol (1978); 1995; 37(3):205-10. PubMed ID: 7567439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.